Illinois Bill Would Require Medication-Assisted Treatment in Every State Prison

Illinois is moving closer to becoming one of the first states to require medication-assisted treatment in every correctional facility, with Senate Bill 2185 advancing through committee this month after supporters pointed to an 89% drop in overdose deaths in a county jail that already offers the program.

The bill, sponsored by State Senator Rachel Ventura (D-Joliet), passed the Senate Criminal Law Committee on Tuesday and now heads to the Senate Appropriations Committee for review of its fiscal impact. If enacted, the legislation would mandate that the Illinois Department of Corrections screen every incarcerated person for substance use disorders within 24 hours of admission and provide medication-assisted treatment or medications for opioid use disorder to anyone who tests positive or shows signs of withdrawal.

The Post-Release Overdose Crisis

Senator Ventura has framed the bill as a response to a grim reality: overdoses are the leading cause of death among people returning to their communities after incarceration. The period immediately following release represents one of the highest-risk windows for a fatal overdose, as tolerance drops during confinement while the pull of prior use patterns often remains strong.

National data underscores the urgency. According to the National Institute on Drug Abuse, fewer than half of jails and prisons surveyed offer any form of medication for opioid use disorder. Only 12.8% make it available to anyone who needs it, leaving the vast majority of incarcerated people with opioid addiction to face release without the medical support that evidence shows can prevent death.

SB 2185 would close that gap in Illinois, mandating not just initial screening but ongoing assessments throughout incarceration and immediate access to medications like buprenorphine, methadone, or naltrexone for anyone who needs them.

A Model That Works: Kane County's 89% Success

The bill is modeled directly on a medication-assisted treatment program operating at the Kane County Adult Justice Center since 2019. Kane County Sheriff Ron Hain has reported that opioid overdose deaths among formerly incarcerated individuals enrolled in the program dropped by 89%—a figure that has become the centerpiece of arguments for statewide expansion.

That single statistic illustrates the life-or-death stakes of the policy choice. In a county jail of roughly 700 people, the program has meant the difference between dozens of people returning safely to their communities and dozens more funerals.

The Kane County model includes medical detox support, access to medication during incarceration, and continuity of care planning before release. It treats opioid use disorder as a chronic medical condition requiring ongoing management, not a moral failing that ends the day someone walks out of a jail cell.

Senator Ventura has argued that the bill is not only compassionate but practical. Treating addiction reduces recidivism, improves public health outcomes, and could lower the long-term costs of incarceration and emergency services. The question now is whether Illinois will choose to replicate success or continue a patchwork approach that leaves most of the incarcerated population without access.

Funding from Those Responsible

One of the bill's most significant features is its funding source: the Illinois Opioid Settlements Initiative, which comprises settlement payments from opioid manufacturers, distributors, and chain pharmacies sued by the Illinois Attorney General for their role in fueling the opioid crisis.

Illinois has allocated $21.8 million from settlement funds to medication-assisted treatment programs in its 2024 annual report, alongside $33 million for warm handoff and recovery services and $24.6 million for prevention. The state is expected to receive hundreds of millions more in settlement payments over the next decade, creating a sustained funding stream that advocates say should be directed toward the populations most affected by the crisis.

Using opioid settlement dollars to fund correctional MAT programs creates a direct accountability loop: pharmaceutical companies that profited from aggressive opioid marketing are, through court settlements, now funding treatment for people incarcerated largely because of opioid use. For supporters of the bill, that connection is both just and practical.

The settlement funding structure also insulates the program from the annual budget fights that often leave addiction treatment vulnerable to cuts. As long as settlement dollars continue flowing, the program would have a protected revenue source independent of general appropriations.

The National Landscape

Illinois would join a small but growing number of states attempting to address the treatment gap in correctional settings. Recent national surveys show deep regional disparities: facilities in the West are three times more likely to offer medication-assisted treatment than those in the Midwest, and many Southern states report single-digit percentages of diagnosed individuals receiving care.

A lawsuit filed earlier this month against Missouri's Department of Corrections alleges systemic denial of medication-assisted treatment despite $7 million in available opioid settlement funds. The lawsuit highlights two deaths—Bradley Ketcherside, who died six days after his third denial of treatment, and Brandon Church, who committed suicide two weeks after being taken off medication while in solitary confinement—as examples of what happens when jails and prisons refuse to treat addiction as a medical condition.

Illinois, by contrast, is attempting a proactive approach. Rather than waiting for litigation or federal consent decrees, the legislature is considering a bill that would establish treatment as a right, not a privilege subject to correctional discretion.

What Happens Next

SB 2185 now moves to the Senate Appropriations Committee, where lawmakers will evaluate its fiscal impact. While the bill is funded through opioid settlements rather than general revenue, appropriations review will assess whether the settlement dollars are sufficient to cover the costs of screening, ongoing assessment, medication procurement, and staff training across all state prisons.

Implementation would also require building infrastructure: medical staff trained in addiction medicine, systems for tracking who has been screened and who is receiving treatment, and protocols for continuity of care when someone is released or transferred between facilities.

The bill does not specify timelines or penalties for noncompliance, which could become points of negotiation as it moves through the legislative process. Some advocates have called for independent oversight to ensure that screening happens within the mandated 24-hour window and that treatment decisions are based on medical need rather than security convenience.

Thousands of incarcerated Illinoisans with opioid use disorder would gain access to medical detox and medication-assisted treatment if the bill becomes law—resources currently out of reach for most. Whether that happens will depend on the political will to fund and implement a program that evidence says works, and that one county has already proven can save lives.